Show simple item record

dc.contributor.authorBygrave, Helen
dc.contributor.authorKranzer, Katharina
dc.contributor.authorHilderbrand, Katherine
dc.contributor.authorJouquet, Guillaume
dc.contributor.authorGoemaere, Eric
dc.contributor.authorVlahakis, Nathalie
dc.contributor.authorTriviño, Laura
dc.contributor.authorMakakole, Lipontso
dc.contributor.authorFord, Nathan
dc.date.accessioned2011-03-24T16:00:58Z
dc.date.available2011-03-24T16:00:58Z
dc.date.issued2011-03
dc.identifier.citationRenal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural lesotho. 2011, 6 (3):e17609 PLoS ONEen
dc.identifier.issn1932-6203
dc.identifier.pmid21407815
dc.identifier.doi10.1371/journal.pone.0017609
dc.identifier.urihttp://hdl.handle.net/10144/125587
dc.description.abstractCurrent guidelines contraindicate TDF use when creatinine clearance (CrCl) falls below 50 ml/min. We report prevalence of abnormal renal function at baseline and factors associated with abnormal renal function from a community cohort in Lesotho.
dc.language.isoenen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleRenal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural lesotho.en
dc.contributor.departmentMédecins Sans Frontières, Morija, Lesotho.en
dc.identifier.journalPloS Oneen
refterms.dateFOA2019-03-04T08:39:06Z
html.description.abstractCurrent guidelines contraindicate TDF use when creatinine clearance (CrCl) falls below 50 ml/min. We report prevalence of abnormal renal function at baseline and factors associated with abnormal renal function from a community cohort in Lesotho.


Files in this item

Thumbnail
Name:
Bygrave PloS One TDF.pdf
Size:
80.46Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record